Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT00623558 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasm

Interventions

DRUG: Cetuximab
DRUG: Docetaxel
DRUG: Cisplatin

Sponsor

Seoul National University Hospital

Collaborators

[object Object]